• The Primary Health Network News
    PHN News & Information

Primary Health Network acquires “Aardvark” mobile health unit

In response to the COVID-19 public health emergency, Primary Health Network recently announced the procurement of a new “Aardvark” mobile unit. This mobile health unit will be used to administer COVID testing and vaccines across the state of Pennsylvania.

Carl Sizer, Primary Health Network’s Acting Finance Director states, “This mobile unit elevates PHN’s COVID response to a new level by providing our clinical staff the ability to test for COVID-19 and administer the vaccine at a high capacity.  Additionally, PHN can respond to needs of the communities we serve by driving this unit to the areas where we can make the greatest impact.” The mobile unit is capable of testing and vaccinating a high volume of patients, can be set up in under 15 minutes, requires considerably less PPE and is climate controlled. Sizer continues, “Our priority is always providing the highest level of care in the safest environment, and we believe this unit accomplishes both of those goals.  We are excited to work with our PHN family, Aardvark Mobile Health, and our state and regional partners as we enter a new territory in health care delivery.”

The purchase of this mobile unit couldn’t come at a more opportune time as the phased distribution of the COVID-19 vaccine has begun. Primary Health Network’s Chief Medical Officer, Dr. George Garrow explains, “Primary Health Network, in partnership with our public health authorities, is working to make the COVID-19 vaccine widely accessible to our communities. Currently, the CDC Advisory Committee on Immunization Practice (ACIP) has made provisions for all health care personnel to be included in the Phase 1a distribution of the vaccine.” Phase 1a includes healthcare personnel paid and unpaid persons serving in healthcare settings who have the potential for direct or indirect exposure to patients or infectious materials. Dr. Garrow continues, “Primary Health Network has been classified as a “pre-positioned vaccine site” and will assist in administering the COVID-19 vaccine to community. Vaccines will be administered in a phased approach based on guidance from the CDC.”

Share this page...